Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Credit Suisse Downgrades Boralex to Neutral

Credit Suisse Downgrades Boralex to Neutral

Credit Suisse analyst Andrew Kuske downgrades Boralex (TSX:BLX) from Outperform to Neutral.

byBenzinga Newsdesk

July 11, 2022

1 minute read

Credit Suisse analyst Andrew Kuske downgrades Boralex (TSX:BLX) from Outperform to Neutral.

Verona Pharma’s Lung Disease Candidate Cuts COPD Exacerbations By 42%

By Vandana Singh

August 9, 7:39 AM

Verona Pharma plc (NASDAQ:VRNA) has announced topline results from Phase 3 ENHANCE-2 of nebulized ensifentrine for the maintenance treatment of chronic…

VRNA

Teva Pharmaceutical Lifts Revenue Forecast – Huntington’s And Migraine Drugs Help Q3 Performance

By Vandana Singh

November 8, 1:07 PM

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) reported Q3 sales of $3.85 billion, beating the consensus of $3.72 billion

TEVA

Kevin O’Leary Says AOC Is ‘Great At Killing Jobs’; Here’s His List of ‘Uninvestable’ States

By Bibhu Pattnaik

March 4, 4:34 PM

O'Shares Investment Advisors chairman and renowned "Shark Tank" investor Kevin O'Leary says that Rep. Alexandria Ocasio-Cortez'

AMZN

Couple Mistakenly Hit With $30K Uber Charge: ‘Bank Basically Says It’s Our Fault’

By Bibhu Pattnaik

July 9, 1:26 PM

During their vacation in Costa Rica, an American couple alleges that they were billed $29,994 for a single Uber (NYSE: UBER) ride.

UBER

Credit Suisse Downgrades Boralex to Neutral

Related Posts

Verona Pharma’s Lung Disease Candidate Cuts COPD Exacerbations By 42%

Teva Pharmaceutical Lifts Revenue Forecast – Huntington’s And Migraine Drugs Help Q3 Performance

Kevin O’Leary Says AOC Is ‘Great At Killing Jobs’; Here’s His List of ‘Uninvestable’ States

Couple Mistakenly Hit With $30K Uber Charge: ‘Bank Basically Says It’s Our Fault’